References
Lucchesi M, Guidi M, Fonte C, Farina S, Fiorini P, Favre C, de Martino M, Sardi I (2016) Pharmacokinetics of high-dose methotrexate in infants aged less than 12 months treated for aggressive brain tumors. Cancer Chemother Pharmacol 77:857–864
Morse M, Savitch J, Balis F, Miser J, Feusner J, Reaman G, Poplack D, Bleyer A (1985) Altered central nervous system pharmacology of methotrexate in childhood leukemia: another sign of meningeal relapse. J Clin Oncol 3:19–24
Csordas K, Hegyi M, Eipel OT, Muller J, Erdelyi DJ, Kovacs GT (2013) Comparison of pharmacokinetics and toxicity after high-dose methotrexate treatments in children with acute lymphoblastic leukemia. Anticancer Drugs 24:189–197
Borsi JD, Wesenberg F, Stokland T, Moe PJ (1991) How much is too much? Folinic acid rescue dose in children with acute lymphoblastic leukaemia. Eur J Cancer 27:1006–1009
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lucchesi, M., Sardi, I. Reply to Prof Ian J. Cohen. Cancer Chemother Pharmacol 78, 219–220 (2016). https://doi.org/10.1007/s00280-016-3061-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00280-016-3061-3